22nd Century Group (Nasdaq: XXII) to Participate in LD Micro, Roth Capital Investor Meetings
BUFFALO, N.Y., May 27, 2024 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. XXII, a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, today announced that James A. Mish, Chief Executive Officer, and Richard Fitzgerald, Chief Financial Officer, will host meetings with investors at two upcoming investor conference events in June 2022.
Institutional investors participating in the conference can request a meeting with management through their institutional representative, or by contacting 22nd Century Group's investor relations team via [email protected].
About 22nd Century Group, Inc.
22nd Century Group, Inc. (Nasdaq:XXII) is a leading agricultural biotechnology company dedicated to improving human health with reduced nicotine tobacco, hemp/cannabis, and hops advanced plant technology, The Company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of theFDA's Comprehensive Planto address the widespread death and disease caused by smoking. The Company received the first and only FDA MRTP authorization of a combustible cigarette in December 2021, now in a pilot marketing program in the United States. In tobacco, hemp/cannabis, and hop plants, 22nd Century uses modern plant breeding technologies, including genetic engineering, gene-editing, and molecular breeding to deliver solutions for the life science and consumer products industries by creating new, proprietary plants with optimized alkaloid and flavonoid profiles as well as improved yields and valuable agronomic traits.
Continue read on benzinga.com